trial

Reducing Internalized Stigma in People With Serious Mental Illness

NCTId NCT01259427
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 2 · Completed
Enrollment 252 (actual)
Sponsored by VA Office of Research and Development
Primary completion 2014-09
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 2
Status
Completed
Enrollment
252 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2011-10
Primary completion
2014-09
Eligibility
ALL · 18 Years · 80 Years

Interventions & indications

Drugs
Ending Self Stigma (ESS)Health and Wellness Group

Sponsors

VA Office of Research and DevelopmentLead Sponsor

Investigators

1
Amy L Drapalski, PhDPrincipal Investigator

Sites

3 total
Washington D.C., United StatesBaltimore, United StatesPerry Point, United States

Linked catalysts

1
Reducing Internalized Stigma in People With Serious Mental Illness — primary completion2014-09

Facts & assertions

4 sourced
Enrollment
252
Phase
PHASE2
Primary Completion Date
2014-09
Status
COMPLETED
relationships
The graph out of here
drug
Ending Self Stigma (ESS)
drug
Health and Wellness Group
drug
lead_sponsor
VA Office of Research and Development
company
indication
Bipolar Disorder
indication
Schizoaffective Disorder
indication
Psychotic Disorders
indication
investigator
Amy L Drapalski, PhD
person